Albumin-muscle density score predicts overall survival in patients with hepatocellular cancer undergoing treatment with transarterial chemoembolization.
Surov A, Wienke A, Borggrefe J, Auer TA, Gebauer B, Mähringer-Kunz A, Nensa F, Haubold J, Schaarschmidt BM, Hosch R, Kleesiek J, Diallo TD, Roehlen N, Bettinger D, Eisenblätter M, Steinle V, Mayer P, Zopfs D, Pinto Dos Santos D, Müller L, Kloeckner R.
Surov A, et al. Among authors: auer ta.
J Cancer Res Clin Oncol. 2024 Nov 30;150(12):515. doi: 10.1007/s00432-024-06043-3.
J Cancer Res Clin Oncol. 2024.
PMID: 39614916
Free PMC article.